← Back to Investors

Omega Funds

Omega Funds is a leading transatlantic life sciences investment firm with offices in Boston and London. They specialize in therapeutics investments, with deep expertise in oncology, immunology, and rare diseases, and a strong track record of backing successful biotech companies.

Location
Boston, Massachusetts, USA
Founded
2004
AUM
$1.5B+
Investment Range
$5M - $75M
Focus
biotech-focused
Fund Stages
seed, series-a, series-b, series-c, growth

Investment Thesis

Omega Funds invests in innovative therapeutics companies with differentiated science and strong clinical potential. They focus on companies developing novel treatments for serious diseases, bringing deep scientific expertise and operational support to help companies progress from discovery through clinical development.

Team

Partners / Managing Directors (Health & Bio Focus)

  • Claudio Nessi - Managing Partner
  • Otello Stampacchia, PhD - Managing Partner
  • Claude Nicaise, MD - Managing Partner
  • Anne-Mari Paster - Partner

Other Key Team Members

  • Team includes MDs, PhDs, and former pharma executives

Focus Areas

  • Therapeutics (oncology, immunology, rare diseases)
  • Drug discovery
  • Novel modalities
  • European biotech
  • US biotech
  • Platform technologies

Notable Exits

  • Strong track record of IPOs and M&A exits
  • Multiple successful oncology investments
  • Experience across therapeutic areas

Sources